News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
Artificial intelligence-powered system designed to deliver adaptive therapy treatment in a typical 15-minute timeslot
September 16, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.
Adaptive therapy provides the ability to alter the treatment plan based on tumor and anatomical changes. The goal is to better target the tumor, reduce dose to healthy tissue and potentially improve overall outcomes.
The streamlined workflow of Ethos therapy is enabled by its AI-driven planning and contouring capabilities. The physician defines their clinical intent from predefined templates and the initial treatment plan is generated based on the physician's intent. The treatment plan is adapted in response to the variability of the tumor's shape and cellular characteristics, along with fluctuations in the tumor's position due to changes in nearby organs. The ability of Ethos to deliver on-couch adaptive treatment puts the patient at the center of care.
Ethos therapy offers the use of multimodality images — including magnetic resonance (MR), positron emission tomography (PET) and computed tomography (CT) — and daily iterative cone beam computed tomography (CBCT) images at the console. By providing an up-to-date view of the patient's anatomy, Ethos therapy provides clinicians the confidence to make more informed adaptive treatment decisions. The solution is built on Varian's latest treatment delivery technology, and provides fast imaging and treatment delivery without compromising quality.
"Ethos therapy will enable our physicians to better visualize the changes in a patient's anatomy and quickly adapt the therapy accordingly to help provide better treatments to patients," said Poul Geertsen, M.D., Ph.D., head of radiotherapy, Department of Oncology at Herlev and Gentofte Hospital, Copenhagen, Denmark. "We have already delivered the first Ethos therapy treatment, and our clinical staff was impressed by the capabilities and the ability to deliver this advanced treatment in a typical timeslot."
To advance the worldwide adoption of intelligent adaptive therapy, Varian formed the Adaptive Intelligence Consortium in April 2019. Participants include clinicians and scientists from leading cancer clinics across the globe. The consortium will lead clinical trials to develop evidence-based clinical protocols for Ethos therapy.
Ethos therapy has received CE mark and is currently U.S. Food and Drug Administration (FDA) 510(k) pending and not for sale in all markets.
Watch the 2019 ASTRO VIDEO: Artificial Intelligence Driven Adaptive Radiotherapy System Begins Treating Patients— Interview withDavid Sjostrom, Ph.D., deputy chief physicist, Herlev Hospital
For more information: www.varian.com
Related Content
News | ACR
ACR Highlights Healthcare-Related Artificial Intelligence Bills in 2024 State Legislative Sessions
June 24, 2024 — Legislative efforts across numerous states in 2024 focused on the integration of artificial intelligence ...
June 24, 2024
Feature | Radiology Business
In Memoriam: Prolific Philanthropist Ann Lurie, Namesake of the Ann and Robert H Lurie Children’s Hospital of Chicago
June 24, 2024 — Well-known Chicago and worldwide philanthropist Ann Lurie, namesake of the Ann and Robert H Lurie ...
June 24, 2024
News | Artificial Intelligence
New Version of Data Standardization Software Now Available
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
June 21, 2024
News | SIIM
Society for Imaging Informatics in Medicine Annual Meeting SIIM24 Program Preview
June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...
June 20, 2024
News | Radiation Therapy
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system
June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...
June 19, 2024
News | Artificial Intelligence
New Study Proves AI Enhances Physicians’ Ability to Identify Extent of Prostate Cancer with 84 Percent Accuracy
June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...
June 17, 2024
News | Proton Therapy
Atlantic Health System and Mevion Announce Plans to Bring Newest Proton Therapy Technology to Cancer Patients
June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...
June 14, 2024
News | PET Imaging
Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)
June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
June 14, 2024
News | FDA
Siemens Healthineers Receives FDA Clearance for High-Performance Biograph Trinion PET/CT Scanner
June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...
June 10, 2024
News | Breast Imaging
Breakthroughs in Breast Cancer: Susan G. Komen(R) Scholars and Studies Highlighted at ASCO 2024
June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...
June 07, 2024
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now